Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, 102218, China
NCT Number: NCT06162520
Congenital biliary dilatation necessitates timely intervention owing to potential complications. This study endeavors to enhance diagnostic precision using quantitative three-dimensional morphological characteristics. Objectives involve developing models to differentiate congenital from secondary biliary dilatation and identify intrahepatic involvement. Employing machine learning, robust diagnostic models aim to elevate clinical detection rates and improve accuracy.
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, Beijing Municipality, 102218, China
Congenital biliary dilatation is a primary anomaly affecting the biliary tract. It can involve the extrahepatic bile ducts, intrahepatic bile ducts, or the entire biliary system, including the common bile duct. Patients with congenital biliary dilatation exhibit abnormal expansion of the bile duct system, which can lead to complications such as bile duct stones, pancreatic inflammation, and even bile duct cancer. Timely and accurate diagnosis, followed by surgical intervention to remove the dilated bile duct lesion, is crucial for the treatment of choledochal dilation. However, the differentiation of congenital biliary dilatation in clinical practice poses challenges, primarily due to the limitations of subjective physician experience and macroscopic imaging features, making it difficult to achieve high sensitivity in discerning congenital biliary dilatation. Particularly, in distinguishing between congenital biliary dilatation and secondary biliary dilatation, the similarities of the bile ducts limit the precision of clinical decisions. Therefore, this study aims to address the current challenges in the differential diagnosis of congenital biliary dilatation and secondary biliary dilatation by quantitatively describing the morphology of dilated bile ducts. Moreover, this study plans to build a predictive model of intrahepatic bile duct dilatation to provide more comprehensive clinical support. Specifically, the research objectives are outlined as follows:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diagnosis models are established using quantitative morphological characteristics extracted from the 3D reconstructed bile duct from contrast-enhanced computed tomography (CECT) images.
Time frame: Pre-operation
The area under the ROC curve is calculated by integrating the ROC curve, which plots Sensitivity against 1 - Specificity.
Time frame: Pre-operation
The area under the precision-recall curve is determined by integrating the Precision-Recall curve, which plots Precision against Recall.
Time frame: Pre-operation
Sensitivity is calculated as the ratio of true positives to the sum of true positives and false negatives.
Time frame: Pre-operation
Specificity is calculated as the ratio of true negatives to the sum of true negatives and false positives.
Time frame: Pre-operation
Accuracy is calculated as the ratio of the sum of true positives and true negatives to the total number of cases.
Tsinghua University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07336576
Bile Duct Diseases, Biliary Tract Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07028164
Bile Duct Diseases, Biliary Tract Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06111872
Bile Duct Diseases, Biliary Tract Diseases
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT06716762
Bile Duct Diseases, Biliary Tract Diseases
Seoul, South Korea
View Trial Details